Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Zhenping Chen
Pre-treatment B-cell activating factor (BAFF)–B-cell imbalance and multi-pathway immune phenotyping are associated with rituximab non-response in pediatric immune thrombocytopenia: a prospective cohort study
Abstract Background: Rituximab is widely used as a second-line therapy for pediatric immune thrombocytopenia (ITP), yet approximately 40% of patients do not respond. The biological determinants of non-response are heterogeneous and incompletely understood. This exploratory study aimed to characterize baseline immune profiles associated with rituximab non-response and to generate hypotheses regarding the underlying mechanisms.
Spatially resolved chromatin architectures in mammalian brain tissues
Abstract Unraveling 3D chromatin architectures is crucial for decoding regulatory programs of development and disease. However, current sequencing-based methods typically profile 3D genome organizations while sacrificing the spatial context of tissues. Here we present spatial high‑throughput chromosome conformation capture (Hi-C), a technology that resolves genome-wide chromatin structures directly within tissue sections.
Pulmonary microbiome analysis and screening of prognostic markers in severe viral pneumonia
Abstract To investigate the association between the pulmonary microbiome and 90-day mortality in patients with severe viral pneumonia using metagenomic next-generation sequencing (mNGS). Cox proportional hazards regression and LASSO regression were used to identify variables associated with prognosis.
Machine learning estimation of FVIII pharmacokinetic parameters in Chinese children with severe Hemophilia A - npj Systems Biology and Applications
Abstract Hemophilia A is a rare inherited bleeding disorder typically managed with coagulation factor VIII (FVIII) replacement therapy.
Effectiveness of sirolimus for early on‐set autoimmune cytopenias of autoimmune lymphoproliferative immunodeficiencies
Corresponding Author Tianyou Wang Beijing Key Laboratory of Pediatric Hematology Oncology; Ministry of Education Key Laboratory of Major Diseases in Children, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China Department of Hematology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China Correspondence Huawei Mao, Department of Rheumatology and Immunology, Beijing Children's...
Clinical Use of Eltrombopag and Avatrombopag in Pediatric ITP in China: A Real‐World Multicenter Retrospective Cohort Study
Low-Dose Immune Tolerance Induction for Severe Hemophilia A Inhibitor Patients: Immunosuppressants Are Generally Not Necessary for Inhibitor-Titer Below 200 BU/ML
It remained unclear that the efficacy comparison between low‐dose immune tolerance induction (LD‐ITI) incorporating immunosuppressants (IS) when severe hemophilia A (SHA) patients had inhibitor‐titer ≥200 Bethesda Units (BU)/mL (LD‐ITI‐IS200 regimen) and LD‐ITI combining with IS when SHA patients had inhibitor‐titer ≥40 BU/mL (LD‐ITI‐IS40 regimen). To compare the efficacy of the LD‐ITI‐IS200 regimen with that of the LD‐ITI‐IS40 regimen for SHA patients with high‐titer inhibitors.
Uncertainty Quantification of Engineering Parameters for a Nuclear Reactor Loaded with Dispersed Fuel Particles
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
UAV-Assisted Wireless Charging Incentive Mechanism Design Based on Contract Theory
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Pharmacokinetic variability of factor VIII concentrates in Chinese pediatric patients with moderate or severe hemophilia A
ABSTRACT Importance The use of factor VIII (FVIII) concentrates under pharmacokinetic (PK) guidance has become the main approach for treatment of hemophilia. However, limited PK research has been conducted in Chinese pediatric patients. Objective To investigate the PK parameters of various FVIII concentrates in Chinese pediatric patients. Methods Seventy‐nine patients were enrolled (28 treated with Kogenate FS®, 23 treated with Advate ®, and 28 treated with GreenMono™).
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Zhenping
Contact Zhenping, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack